Several companies, including a few with Utah connections, reported quarterly financial results on Thursday.
Headwaters
South Jordan-based Headwaters Inc. reported net income of $27.4 million, or 58 cents per share, for the quarter ended June 30. That compares with $55.3 million, or $1.17 per share, for the same quarter last year.
Revenue for the third fiscal quarter totaled $295.9 million, down from $308.7 million in the year-earlier quarter.
The company is involved in the alternative energy technologies, construction and home-improvement industries.
The company's stock rose 57 cents Thursday to close at $21.42. During the past year, the price has ranged from $20.54 to $45.75.
Nutraceutical
Park City-based Nutraceutical International Corp. reported net income of $3.4 million, or 29 cents per share, for the fiscal third quarter ended June 30. That compares with $3.2 million, or 27 cents per share, for the prior-year quarter.
Sales totaled $37 million, down from $37.2 million a year earlier.
The company manufactures, markets, distributes and retails nutritional supplements and other natural products
Nutraceutical stock fell 29 cents Thursday to close at $13.84. During the past year, the price has ranged from $11.51 to $17.08.
Iomega
San Diego-based Iomega Corp., which has about 250 employees in Utah, reported a net loss of $10.4 million, or 20 cents per share, for the quarter ended July 2. That compares with a loss of $6.4 million, or 12 cents per share, for the prior-year quarter.
Revenue totaled $40.7 million, down from $65.7 million.
The company produces data storage products. Its stock fell 12 cents Thursday to close at $2.30 its lowest point in at least a year. During the past year, the price has been as high as $3.95.
Omniture
Orem-based online business software company Omniture Inc. reported a net loss of $2.3 million, or 16 cents per share, for the second quarter ended June 30. That compares with a loss of $3.7 million, or 27 cents per share, for the year-earlier quarter.
Revenue was a company-record $18.8 million, up from $9.5 million a year earlier.
Omniture stock rose 5 cents Thursday to close at $6.95. During the past year, the price has ranged from $5.60 to $7.98.
Merit Medical
South Jordan-based Merit Medical Systems Inc. reported net income of $3.5 million or 13 cents per share, for the second quarter ended June 30. That compares with $4.7 million, or 17 cents per share, for the same quarter in 2005.
Revenues were a company-record $48.1 million, up from $42.4 million in the prior-year quarter.
Merit develops, manufactures and distributes disposable medical accessories used in interventional and diagnostic procedures. Merit employs approximately 1,630 people worldwide, with facilities in Salt Lake City and South Jordan; Santa Clara, Calif.; Angleton, Texas; Richmond, Va.; the Netherlands and Ireland.
The company's stock fell 51 cents Thursday to close at $13.31. During the past year, the price has ranged from $10.60 to $18.29.
Convergys
Convergys Corp. reported net income of $39.8 million, or 28 cents per share, for the second quarter. That compares with $25.6 million, or 18 cents per share, in the year-earlier quarter.
Revenue totaled $691.8 million, up 10 percent from $630.4 million.
Convergys has about 8,300 workers at six call centers in Utah.
Convergys stock rose 3 cents Thursday to close at $18.47. During the past year, the price has ranged from $13.58 to $19.87.
Comcast
Comcast Corp., the nation's largest cable TV operator, said its second-quarter net income rose 7 percent from a year ago as revenue soared, highlighted by a leap in subscribers for its Internet telephone service.
Philadelphia-based Comcast earned $460 million, or 22 cents per share, compared with $430 million, or 19 cents, in the same period a year ago. Revenue came in at $6.23 billion, up 11 percent from last year's $5.6 billion.
During trading, shares of Comcast hit $34.33 — a new 52-week high — on the Nasdaq, before closing at $34.02, up $1.50, or 4.6 percent.
Comcast said the second-quarter results do not include its acquisition of Adelphia Communications Corp.'s assets, which is expected to close on Monday. The Adelphia purchase should add slightly to earnings, the company said.
L-3
L-3 Communications Holdings Inc., a maker of battlefield communications systems for the U.S. military, said second-quarter earnings fell 58 percent on legal costs and stock option expenses.
Net income fell to $49.8 million, or 40 cents a share, from $119.4 million, or 99 cents, a year earlier, New York-based L-3 said. Sales rose 49 percent to $3.08 billion.
Communications Systems-West, the Salt Lake division of L-3, employs 2,300 people in Utah
L-3 shares fell $2.44, or 3.2 percent, to close at $73.79 in New York Stock Exchange composite trading. They have fallen 5.5 percent in the past year.
Northrop Grumman
Northrop Grumman Corp., the world's largest warship builder, said second-quarter earnings rose 17 percent as a tax gain and improved profit margins on submarines helped overcome delays at its shipyards after Hurricane Katrina.
Net income rose to $430 million, or $1.23 a share, from $367 million, or $1, a year earlier. Sales fell 2.6 percent to $7.6 billion, the company said.
Northrop Grumman has about 1,250 employees in Utah.
Shares of Northrop fell 97 cents to close at $65.96 at in New York Stock Exchange composite trading. They have gained 16 percent in the past year.
Edo
Edo Corp., which makes radio-signal jamming devices for the U.S. Defense Department, said second-quarter net income rose to $6.27 million, or 30 cents a share, from $6.09 million, or 31 cents, a year earlier.
Revenue fell to $152.4 million from $156.1 million a year earlier on production of its electronic force-protection products, which can detect weapons as they approach a military unit.
Edo also said Thursday it has agreed to acquire two closely held companies, CAS Inc. and Impact Science & Technology Inc., for a combined $299.6 million to expand its offerings to government agencies.
Edo has its Edo Electro-Ceramic Products and Edo Fiber Science business segments based in Salt Lake City.
Edo shares fell 17 cents to close at $22.82 in New York Stock Exchange composite trading. They have fallen 25 percent in the past year.
Holly Energy
Dallas-based Holly Energy Partners LP reported net income of $3 million, or 17 cents per share, for the second quarter ended June 30. That compares with $6 million, or 40 cents per share, for the same quarter a year ago.
Revenues totaled $18.5 million, down from $19.5 million in the prior-year quarter.
Holly Energy Partners provides refined petroleum product transportation and terminal services to the petroleum industry, including Holly Corp., which owns a 45 percent interest in the partnership. The partnership owns and operates refined product pipelines and terminals in several states, including Utah. Holly Corp. operates a refinery in Woods Cross.
The company's stock fell 25 cents Thursday to close at $40.15. During the past year, the price has ranged from $35.80 to $45.40.
Boston Scientific
Heart device maker Boston Scientific Corp. said it swung to a second-quarter loss because of costs related to its recent $27 billion acquisition of Guidant Corp. The deal helped boost sales by more than 30 percent.
The company reported a loss of $4.26 billion, or $3.21 per share, for the three months ended June 30 compared with a profit of $205 million, or 24 cents per share, a year ago.
The latest quarter included charges of $4.54 billion, or $3.42 per share, made up primarily of a $4.18 billion non-cash charge for acquired research and development assets from Guidant. Amortization costs and expenses for stock-option compensation amounted to 10 cents per share.
Excluding one-time charges, the amortization costs and stock option expenses, the company reported net income of $412 million, or 31 cents per share.
Revenue rose 31 percent to $2.11 billion from $1.62 billion last year, with the bulk of the increase contributed by the addition of Guidant.
Boston Scientific in June 2005 completed its acquisition of Salt Lake-based Rubicon Medical Corp.
The company's shares rose 69 cents, or 4 percent, to close at $17.75 on the New York Stock Exchange. Its shares are down about 27.5 percent from the start of the year.
SuperGen
California-based SuperGen Inc. reported net income of $4.3 million, or 8 cents per share, for the quarter ended June 30. That compares with $1.9 million, or 4 cents per share, for the year-earlier quarter.
Revenues totaled $24 million, up from $7.9 million.
SuperGen announced in January that it planned to acquire Montigen Pharmaceuticals Inc., a privately held oncology-focused drug discovery and development company headquartered in Salt Lake City.
SuperGen stock fell 12 cents Thursday to close at $3.53. During the past year, the price has ranged from $3.18 to $7.24.
Contributing: Associated Press, Bloomberg News